Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

R&D Market Pulse: Qualcomm Hurt by FTC Court Ruling

By Tim Studt | May 28, 2019

The R&D Index for the week ending May 24, 2019 closed at 4,549.64 for the 25 companies in the R&D Index. The Index was down -2.28% (or 106.07 basis points) from the week ending May 17, 2019. Ten of the 25 R&D Index members gained value from 0.13% (Toyota) to 5.83% (Novartis). Fifteen of the 25 R&D Index member lost value from -0.09% (Bristol-Myers Squibb) to -18.76% (Qualcomm).

R&D Index member Qualcomm fell sharply last Wednesday after a U.S. district court ruled in favor of the Federal Trade Commission in its antitrust lawsuit against Qualcomm. Apple and Qualcomm settled their licensing lawsuit in late April, however the FTC lawsuit covered many of the same issues stating that Qualcomm used its strong position in the wireless chip market to charge excessive royalties for its patents, thereby unlawfully hurting competition. The judge ordered Qualcomm to renegotiate its licensing agreements. Qualcomm is appealing the judgement. The company’s stock was down nearly 19% for the week, but is still up 16% for the year.

A recent study by the Harvard Business Review (HBR) revealed that corporate R&D spending now dramatically outpaces corporate advertising spending by a factor of 10 to one. In the 1970s, R&D and advertising levels as a function of company expenses were about the same. In the late-1990s, corporate R&D declined to about 8%, but since then has steadily increased to more than 14%. HBR studied more than 33,000 unique companies from 1975 to 2017 in their report.

On June 10, Ford Motor Co. is scheduled to inaugurate its new R&D center in Tel Aviv, Israel, which will be dedicated to autonomous driving and other advanced automotive technologies. In January, Ford committed $11 billion in investments by 2022 to have 40 gas-electric hybrid and 22 battery-powered fully electric vehicles in its model lineup. The company has also committed to introduce a fully autonomous vehicle by 2021.

A report in the Wall Street Journal last week noted that the Commerce Department has sharply slowed approvals over the past year by U.S. semiconductor companies to hire Chinese nationals for advanced engineering jobs. While approvals in 2018 often took several weeks, today those same approvals are now taking six to eight months. From 2013 to 2017, Chinese nationals accounted for more than 60% of approved employment licenses from the Commerce Department.

      R&D Index Week Ending May 17, 2019      
    Ticker Exchange 2018 R&D millions U.S. $ 05/17/19 05/24/19 5/24/19 to 5/17/19 5/24/19 to 12/31/18
1 Amazon AMZN NASDAQ 26,750 1,869.00 1,823.28 -2.45% 21.39%
2 Alphabet/Google GOOGL NASDAQ 18,796 1,168.78 1,138.61 -2.58% 8.96%
3 Apple AAPL NASDAQ 14,037 189.00 178.97 -5.31% 13.46%
4 Intel INTC NASDAQ 13,702 44.89 44.57 -0.71% -5.03%
5 Microsoft MSFT NASDAQ 13,558 128.07 126.24 -1.43% 24.29%
6 Roche Pharm RHHBY OTC 12,284 32.84 34.00 3.53% 9.40%
7 Johnson & Johnson JNJ NYSE 11,493 138.61 138.85 0.17% 7.59%
8 Merck & Co. MRK NYSE 11,323 78.72 81.17 3.11% 6.23%
9 Volkswagen AG VWAGY OTC 10,915 16.60 16.18 -2.53% 3.72%
10 Toyota TM NYSE 10,848 118.40 118.55 0.13% 2.13%
11 Novartis NVS NYSE 8,934 82.70 87.52 5.83% 1.99%
12 Honda HMC NYSE 8,180 25.63 25.44 -0.74% -3.82%
13 Pfizer PFE NYSE 7,942 41.47 41.95 1.16% -3.89%
14 Daimler DDAIY OTC 7,615 59.50 53.30 -10.42% 1.00%
15 General Motors GM NYSE 7,278 37.00 35.12 -5.08% 4.99%
16 Oracle ORCL NYSE 7,001 54.50 52.77 -3.17% 16.88%
17 Bristol-Myers Squibb BMY NYSE 6,981 46.85 46.81 -0.09% -9.95%
18 Eli Lilly Co LLY NYSE 6,769 116.01 116.79 0.67% 0.92%
19 GlaxoSmithKline GSK NYSE 6,394 39.46 40.18 1.82% 5.16%
20 Cisco CSCO NASDAQ 6,009 56.35 54.37 -3.51% 25.48%
21 IBM IBM NYSE 5,842 134.32 132.28 -1.52% 16.37%
22 Bayer AG BAYN OTC 5,743 15.83 15.18 -4.11% -13.60%
23 Astra Zeneca PLC AZN NYSE 5,483 37.78 39.02 3.28% 2.74%
24 Qualcomm QCOM NASDAQ 5,183 81.50 66.21 -18.76% 16.36%
25 Sanofi SA SNY NYSE 4,694 41.90 42.28 0.91% -2.60%
  Total     243,754 4,655.71 4,549.64 -2.28% 12.97%
                 
      Biopharmaceutical 672.17 683.75 1.72% 1.92%
      Automotive 257.13 248.59 -3.32% 1.74%
      ICT   1,857.41 1,796.02 -3.31% 11.54%

About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2019 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

Related Articles Read More >

FDA looks to ban nicotine in cigarettes, in this week’s R&D Power Index
Inflation may slow, but R&D still hot, in this week’s R&D Power Index
Inflation and responses will affect R&D plans, in this week’s R&D Power Index
R&D and inflation both increasing globally, in this week’s R&D Power Index
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars